Acadia Pharmaceuticals buy Bank of America Co.
Start price
25.03.26
/
50%
€19.04
Target price
25.03.27
€24.99
Performance (%)
-1.94%
Price
14.04.26
€18.67
Summary
This prediction is currently active. With a performance of -1.94%, the BUY prediction for Acadia Pharmaceuticals by Bank_of_America_Co_ is down slightly. This prediction currently runs until 25.03.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Acadia Pharmaceuticals | -2.072% |
| iShares Core DAX® | 4,24 % |
| iShares Nasdaq 100 | 4,89 % |
| iShares Nikkei 225® | 9,40 % |
| iShares S&P 500 | 3,53 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $29.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat